CILLO, UMBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 35.402
EU - Europa 4.210
AS - Asia 2.544
SA - Sud America 26
OC - Oceania 17
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 8
Totale 42.218
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 35.368
CN - Cina 1.913
IT - Italia 1.567
FI - Finlandia 798
DE - Germania 570
SE - Svezia 500
VN - Vietnam 419
GB - Regno Unito 297
UA - Ucraina 267
IN - India 92
HK - Hong Kong 66
IE - Irlanda 52
FR - Francia 49
CA - Canada 27
RU - Federazione Russa 27
NL - Olanda 17
AU - Australia 12
BR - Brasile 12
ES - Italia 12
BE - Belgio 11
IL - Israele 10
JP - Giappone 9
CH - Svizzera 7
GR - Grecia 7
IR - Iran 7
BZ - Belize 6
CO - Colombia 6
EU - Europa 6
PL - Polonia 6
SC - Seychelles 6
NZ - Nuova Zelanda 5
RO - Romania 5
TR - Turchia 5
BG - Bulgaria 4
KR - Corea 4
CL - Cile 3
NO - Norvegia 3
PH - Filippine 3
PT - Portogallo 3
SG - Singapore 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AR - Argentina 2
CI - Costa d'Avorio 2
ID - Indonesia 2
PE - Perù 2
SA - Arabia Saudita 2
AT - Austria 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
HR - Croazia 1
KE - Kenya 1
KZ - Kazakistan 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
PK - Pakistan 1
SI - Slovenia 1
Totale 42.218
Salva come PNG Salva come JPEG
Città #
Fairfield 6.202
Woodbridge 4.087
Houston 3.022
Ann Arbor 2.910
Chandler 2.584
Ashburn 2.580
Seattle 2.292
Cambridge 2.068
Wilmington 2.025
Jacksonville 1.313
Princeton 744
San Diego 704
Des Moines 489
Beijing 451
Dong Ket 414
Medford 401
Padova 398
Helsinki 375
Nanjing 302
Roxbury 262
Boardman 216
Guangzhou 138
Shenyang 134
Nanchang 125
Hebei 85
New York 75
London 73
Jinan 69
Jiaxing 63
Falls Church 59
Milan 56
Shanghai 55
Redwood City 54
Norwalk 52
Ogden 52
Dearborn 50
Dublin 50
Changsha 48
Rome 48
Tianjin 48
Los Angeles 40
Pune 30
Bologna 28
Chicago 28
Detroit 26
Indiana 26
Kunming 26
Zhengzhou 26
Munich 25
Hangzhou 24
Kharkiv 24
Hefei 23
Kilburn 23
Las Vegas 23
Ningbo 22
Nürnberg 22
Taizhou 22
Washington 21
San Jose 20
Borås 19
Fuzhou 18
Lanzhou 16
Florence 15
Rockville 15
Verona 15
Prescot 14
Palermo 13
Hounslow 12
Mumbai 12
Treviso 12
Bari 11
Buffalo 11
Haikou 11
Taiyuan 11
Turin 11
Vicenza 11
Hanover 10
Lappeenranta 10
Phoenix 10
Tappahannock 10
Acton 9
Chiswick 9
Esslingen am Neckar 9
Paris 9
Portici 9
Brescia 8
Cologno Monzese 8
Hong Kong 8
Legnaro 8
San Francisco 8
Selvazzano Dentro 8
Leawood 7
Pescara 7
Saint Louis 7
Southwark 7
Teramo 7
Udine 7
Belize City 6
Brussels 6
Dolo 6
Totale 36.072
Salva come PNG Salva come JPEG
Nome #
TRAPIANTO DI FEGATO CON EMITRASPOSIZIONE PORTO-CAVALE IN PAZIENTE CON BASM SYNDROME 622
Importance of primary indication and liver function between stages: Results of a multicenter Italian audit of ALPPS 2012-2014 169
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study. 162
Cavoportal hemitransposition associated to portoportal anastomosis for liver transplant in portomesenteric thrombosis. 157
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial 157
Prognostic impact of model for end-stage liver disease score in patients undergoing liver transplantation with suboptimal livers. 148
Circulating free DNA in the progression of liver damage to hepatocellular carcinoma 148
Alcohol abuse and de novo tumors in liver transplantation 148
Model for end-stage liver disease-sodium and survival benefit in liver transplantation. 144
Use of N-acetylcysteine during liver procurement: A prospective randomized controlled study. 144
Validation of the BCLC prognostic system in surgical hepatocellular cancer patients. 143
Fulminant hepatic failure: the issue of patient selection for hazardous liver assistance 142
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation:the first report on the application of VAC therapy 141
Use of grafts from anti-HBc-positive donors in liver transplantation: a 5-year, single-center experience. 141
Administration of hepatic stimulatory substance alone or with other liver growth factors does not ameliorate acetaminophen-induced liver failure. 140
When to perform hepatic resection for intermediate-stage hepatocellular carcinoma 140
Partial hepatectomy as first-line treatment for patients with hepatocellular carcinoma 139
Courage and representations of death in patients who are waiting for a liver transplantation 139
Prognostic Evaluation of the Donor Risk Index Among a Prospective Cohort of Italian Patients Undergoing Liver Transplantation 139
Torque Teno Virus: any pathological role in liver transplanted patients? 137
A National Mandatory-Split Liver Policy: A Report from the Italian Experience 137
A New Liver Autotransplantation Technique Using Subnormothermic Machine Perfusion for Organ Preservation in a Porcine Model 137
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial 132
Treatment of hepatocellular carcinoma in the Precision Medicine era: from treatment stage migration to therapeutic hierarchy 132
Human Liver Autofluorescence: An Intrinsic Tissue Parameter Discriminating Normal and Diseased Conditions 131
Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features 130
Isoniazid-related fulminant hepatic failure in a child: assessment of the native liver's early regeneration after auxiliary partial orthotopic liver transplantation. 130
Prospective validation of the Barcelona Clinic Liver Cancer staging system 130
Reply: The easiest way to improve the outcome of suboptimal liver grafts 129
Representing Subnormothermic Machine Perfusion in Fatty Livers: The Complete Picture? 128
Cost-effectiveness of Pre-Transplant Sofosbuvir for Preventing Recurrent HCV Infection after Liver Transplantation. 127
The survival benefit of liver transplantation in hepatocellular carcinoma patients 126
Hepatitis C Virus Adversely Affects Quality of Life 126
Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: A new exception to MELD score in the allocation system to liver transplantation? 125
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 125
Sequential versus "ab initio' combined diuretic treatment of moderate ascites in cirrhotic patients: Final results of a randomized controlled multicenter clinical study 124
Nonadherent Behaviors After Solid Organ Transplantation 123
Successful transplantation of an injured liver 123
Cross-talk between PDGF and S1P signalling elucidates the inhibitory effect and potential antifibrotic action of the immunomodulator FTY720 in activated HSC-cultures. 123
Hepatic Resection for Disappearing Liver Metastasis: a Cost-Utility Analysis 123
12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus. 122
Liver Resection Associated With Mini Porto-Caval Shunt as Salvage Treatment in Patients With Progression of Hepatocellular Carcinoma Before Liver Transplantation: A Case Report 122
A new experimental model of isolated perfused pig liver to support acute hepaticfailure. 121
Adjuvant chemotherapy for transplanted hepatocellular carcinoma patients: impact on survival or HCV recurrence timing 121
The two faces of hepatocellular carcinoma prognostic evaluation: 'observational' or 'pragmatic' approach? 121
Growth hormone/insulin-like growth factor 1 axis recovery after liver transplantation: A preliminary prospective study 120
The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? 120
A PRIORITIZATION MODEL FOR LIVER TRANSPLANTATION BASED ON A DUAL WAITING LIST: A PROSPECTIVE CONTROLLED STUDY 119
Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the milan criteria 119
Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis 119
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study. 119
Laparoscopic Ablation of Hepatocellular Carcinoma in Cirrhotic Patients Unsuitable for Liver Resection or Percutaneous Treatment: A Cohort Study 119
Double autologous bone marrow transplantation and orthotopic liver transplantation in a patient with primary light chain (AL) amyloidosis. 118
Multicentre evaluation of case volume in minimally invasive hepatectomy 118
Percutaneous radiofrequency thermal ablation for hepatocellular carcinoma. 118
A comparative prospective study of two available solutions for kidney and liver preservation 117
Donor-Model for End-Stage Liver Disease and Donor-Recipient Matching in Liver Transplantation 117
Liver radiofrequency ablation as emergency treatment for a ruptured hepatocellular carcinoma: a case report 117
Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER study 117
Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation. 117
Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine. 116
Prognostic role of BAP-1 and PBRM-1 expression in intrahepatic cholangiocarcinoma 116
Psychosocial Support in Liver Transplantation: A Dyadic Study With Patients and Their Family Caregivers 116
A multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation 115
Long-Term Follow-Up and Outcome of Liver Transplantation From Anti-Hepatitis C Virus-Positive Donors: A European Multicentric Case-Control Study 115
A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation. 115
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC 115
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy 115
Predictors of unresectability in hepatoblastoma: A 20-year single centre report 114
EXTREME MARGINAL DONOR: SEVERE HYPOTHERMIA AS A RARE PRESERVATION CONDITION FOR EXPLANTABLE ORGANS - A CASE REPORT 114
Alphafetoprotein and Transplant Survival Benefit For Patients With Hepatocellular Carcinoma: A Multicentre Cohort Study 114
Covert hepatic encephalopathy: agreement and predictive validity of different indices 114
Neoadjuvant sirolimus for a large hepatic perivascular epithelioid cell tumor (PEComa) 114
Central Nervous System Infectious Complications Early After Liver Transplantation 113
Syngeneic living-donor liver transplantation for hemangioendothelioma: a clinical model for studying liver regeneration 113
Microwave Thermal Ablation for Hepatocarcinoma: Six Liver Transplantation Cases 113
Laparoscopic microwave thermal ablation for late recurrence of local hepatocellular carcinoma after liver transplant: case report. 113
Antibiotic prophylaxis for preventing postorthotopic liver transplant tuberculosis: is there a safe alternative to isoniazid? 113
Drop-out rate from the liver transplant waiting list due to HCC progression in HCV-infected patients treated with direct acting antivirals. 113
Surgery for cholangiocarcinoma 113
Extraordinary disease-free survival in a rare malignant extrarenal rhabdoid tumor: A case report and review of the literature 113
Monoclonal gammopathy after liver transplantation: a risk factor for long-term medical complications other than malignancies. 112
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study 112
Lyn-mediated mitochondrial tyrosine phosphorylation is required to preserve mitochondrial integrity in early liver regeneration. 111
Meld-na and Survival Benefit In Liver Transplantation 111
Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 111
Hepatitis C virus-related cirrhosis as a significant mortality factor in intention-to-treat analysis in liver transplantation 110
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation: the first report on the application of VAC therapy 110
Tacrolimus-based dual therapy is as efficacious and safe as the conventional tacrolimus-based triple therapy in liver transplantation 109
De novo tumors are a major cause of late mortality after orthotopic liver transplantation. 109
Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies 109
Including Relative Adrenal Insufficiency in Definition and Classification of Acute-on-Chronic Liver Failure 109
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis 108
Endoscopic treatment of bile duct complications after orthotopic livertransplantation. 108
Liver Transplantation In Cirrhotic Patients With Meld Score < 18: A New Prognostic Model To Predict Drop-out From the Waiting List 108
Correction to: Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry (Updates in Surgery, (2017), 69, 3, (271-283), 10.1007/s13304-017-0489-x) 108
Videolaparoscopic microwave ablation in patients with HCC at a European high-volume center: Results of 815 procedures 108
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation: the first report on the application of VAC therapy 107
TRAPIANTO DI FEGATO PER EPATOCOLANGIOCARCINOMA INCIDENTALE: ESPERIENZA DI CENTRO 107
"DAA in patients with Hepatocellular carcinoma before Liver Transplantation: are we sure is still an open issue?" 107
Totale 12.813
Salva come PNG Salva come JPEG
Categoria #
all - tutte 142.947
article - articoli 126.149
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 429
Totale 269.525
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193.133 0 0 0 0 0 0 0 0 0 654 1.344 1.135
2019/20209.379 1.144 430 223 782 953 690 965 1.083 1.082 997 636 394
2020/20217.095 394 576 411 566 272 472 397 632 915 800 793 867
2021/20228.287 238 898 985 522 319 537 1.229 661 353 180 934 1.431
2022/20235.746 1.133 523 108 682 872 826 121 402 717 53 230 79
2023/20242.606 201 492 349 262 222 276 254 193 142 215 0 0
Totale 42.740